# Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

> **NCT06707194** · PHASE4 · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 340 (estimated)

## Conditions studied

- Spondyloarthritis (SpA)
- Ankylosing Spondylitis (AS)

## Interventions

- **BIOLOGICAL:** Etanercept
- **DRUG:** Benzathine Penicillin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06707194
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-14
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-07-31
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707194, "Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06707194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*